Radiotherapy for nasopharyngeal carcinoma

Titre traduit de la contribution: Radiothérapie des cancers du nasopharynx

P. Maingon, P. Blanchard, F. Bidault, L. Calmels

    Résultats de recherche: Contribution à un journalBrève enquêteRevue par des pairs

    10 Citations (Scopus)

    Résumé

    Nasapharyngeal carcinoma is a rare disease. Oftenly, the diagnostic is made for advanced disease. Localized tumors, T1 or T2 NO observed a good prognosis and are locally controlled in more than 90 % of the cases by radiotherapy alone. The standard treatment of locally advanced disease is combined chemoradiation. A special vigilance of fast decrease of the volume of the pathological lymph nodes, sometimes associated to loss of weight might indicate an adaptive dosimetric revision. The treatment of recurrent disease is of great importance. Surgical indications are limited but should be discussed in multidisciplinary tumor board when possible. Surgical nodal sampling has to be proposed for nodal recurrence as well as reirradiation, which could be indicated according to the technical issues.

    Titre traduit de la contributionRadiothérapie des cancers du nasopharynx
    langue originaleAnglais
    Pages (de - à)S104-S109
    journalCancer/Radiotherapie
    Volume20
    Les DOIs
    étatPublié - 1 sept. 2016

    Contient cette citation